Patents28 Aug 2021 12:48
Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD and natural resources company, is pleased to announce that it has filed US patent applications for its method of manufacturing of its Chill brand of THC-free, smokable CBD products (the "Patent"). This patent-pending method also includes a variation smoking cessation product, employing combinations of nicotine and CBD, which is also THC-free. The Patent has been in development by the Company for over a year.
The Company believes that CBD may play a rapidly increasing role in smoking cessation aides, and that its Chill branded tobacco-free, THC-free and nicotine-free products are well-placed to take an increasing share of this market, and that the Patent will provide the Company, if it is issued, with a protected market-leading offering. The Smoking Cessation market was estimated to be worth around $4 bn in 2019 in the USA, with significant growth forecast (Source: Grand View Research).